Antifungal resistance and over-the-counter availability in the UK: A current perspective

Journal of Antimicrobial Chemotherapy

Volumn 48, Issue 3, 2001, Pages 345-350

  Hudson, M M T ^a  

^a MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

10 UNDECENOIC ACID; ALLYLAMINE; AMPHOTERICIN; ANTIFUNGAL AGENT; BENZOIC ACID; BIFONAZOLE; BIOCIDE; CALCIUM DERIVATIVE; CLOTRIMAZOLE; CYTOKINE; ECONAZOLE; FENTICONAZOLE; FLUCONAZOLE; IMIDAZOLE; ISOCONAZOLE; KETOCONAZOLE; MICONAZOLE; NON PRESCRIPTION DRUG; NYSTATIN; POLYENE; PYRIDINE; PYRIMIDINE; PYRROLE; STEROID; TERBINAFINE; THIOCARBAMIC ACID; TIOCONAZOLE; TOLNAFTATE; UNDECYLENATE ZINC; UNINDEXED DRUG;

BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG CLASSIFICATION; DRUG RESISTANCE; EPIDEMIOLOGICAL DATA; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MYCOSIS; ORGAN TRANSPLANTATION; REVIEW; UNITED KINGDOM;

EID: 0034812753     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/48.3.345     Document Type: Review

References (23)

1. Investigators seeking new ways to stem rising tide of resistant fungi
2. Mechanisms of resistance to azole antifungals
3. Clinical, cellular and molecular factors that contribute to antifungal drug resistance
4. Increased mRNA levels of ERG16, CDR and MDR1 correlate with increases in azole resistance in Candida albicans isolates from patients infected with human immunodeficiency virus
5. Changing the legal classification in the United Kingdom of prescription only medicine for human use
6. Changing the legal classification in the in the United Kingdom of a medicine for human use from pharmacy to general sale list
7. Susceptibility testing of fungi: Current status of correlation of in vitro data with clinical outcome
8. Update on antifungal resistance
9. Risk factors for fluconazole resistant Candida in patients with AIDS: Prevalence and microbiology
10. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period
11. The changing face of candidaemia-emergence of non-Candida albicans species and antifungal resistance
12. Drug resistance in human pathogenic fungi
13. Prospect of over-the-counter antibiotics
14. Skin and nail fungi-almost beaten
15. Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerations
16. Memorandum on antifungal agents
17. Scedosporium prolificans, a multi-resistant fungus, from a UK AIDS patient
18. Women's use of over-the-counter antifungal medications for gynecologic symptoms
19. The European non-prescription skin care market
20. Environmental and economic effects of reducing pesticide use
21. Molecular mechanisms of drug resistance in fungi
22. Biocides: Mechanisms of antifungal action and fungal resistance